Search
for
Sort by
Research 121–150 of 1000+
- Association of cicatricial alopecia with chemical hair straightening
- 62823 Optimization of deuruxolitinib dosing in adult patients with alopecia areata: Results from a randomized, parallel-group, multicenter, Phase 2 trial
- A review of Janus kinase inhibitor use in scarring alopecia
- A phase 2a study investigating the effects of ritlecitinib on brainstem auditory evoked potentials and intraepidermal nerve fiber histology in adults with alopecia areata
- Correlation of clinical and trichoscopy features with the degree of histologic inflammation in lichen planopilaris and frontal fibrosing alopecia in a cross-sectional study
- The Relationship Between Patient-Reported Severity of Hair Loss and Health-Related Quality of Life and Treatment Patterns Among Patients with Alopecia Areata
- Brigham Eyebrow Tool for Alopecia: A Reliable Assessment of Eyebrow Alopecia Areata
- A Potential Role for IL-4 and IL-13 in an Alopecia Areata–Like Phenotype: A Clinical Perspective
- Real-world experience quantifying access to JAK inhibitor care for alopecia areata patients: a patient-centered survey study
- Factors associated with quality of life in patients with central centrifugal cicatricial alopecia: A cross-sectional study
- Topical tofacitinib for patients with lichen planopilaris and/or frontal fibrosing alopecia
- Drug-induced alopecia areata: A systematic review
- 34007 Efficacy and safety of baricitinib in adult patients with severe alopecia areata with or without an atopic background from 2 randomized, placebo-controlled, phase 3 trials
- Increased risk of vitamin D deficiency and insufficiency in Black patients with central centrifugal cicatricial alopecia
- Characterizing the role of facial hair in gender identity and expression among transgender men
- A pilot evaluation of scalp skin wounding to promote hair growth in female pattern hair loss
- Supplement use among women experiencing hair loss
- Gender‐related cost discrepancies in a cohort of 110 facial moisturizers
- 41701 Efficacy of the Oral JAK1/JAK2 Inhibitor CTP-543 (Deuruxolitinib) in Adult Patients with Moderate to Severe Alopecia Areata: Results from the Multinational Double-Blind, Placebo-Controlled THRIVE-AA1 Phase 3 Trial
- Use of virtual reality during scalp injections: A randomized interventional crossover study
- Association of resilience and perceived stress in patients with alopecia areata: A cross-sectional study
- Undiagnosed cicatricial alopecia among new patients undergoing platelet-rich plasma
- Updated Integrated Safety Analysis of Ritlecitinib Up to ~5 Years in Patients With Alopecia Areata From the ALLEGRO Clinical Trial Program
- Randomized Controlled Trial of the Topical Jak Inhibitor Delgocitinib Cream in Patients with Frontal Fibrosing Alopecia
- Alopecia areata: A clinical review of the changing landscape with Janus kinase inhibitors
- Long-term Efficacy and Safety of Ritlecitinib in Adults and Adolescents with Alopecia Areata: 3-year Results from the ALLEGRO-LT Phase 3, Open-label Study
- Oral gabapentin for scalp pruritus in patients with lichen planopilaris: A case series
- Scalp atrophy secondary to steroid use in patients with scarring alopecia: are topical steroids superior to topical calcineurin inhibitors?
- 42004 Scalp, eyebrow, and eyelash hair regrowth with continued ritlecitinib treatment among patients with alopecia areata without target efficacy response at Week 24: post hoc analysis of the ALLEGRO phase 2b/3 study
- Eyebrows and Eyelashes Regrowth Across Different SALT Response Thresholds in Patients with Alopecia Areata: Outcomes from the BRAVE AA Clinical Program